📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophy. (2013)

First Author: Aoki Y

Attributed to: Confidence in Concept 2012 - University of Oxford funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1155/2013/402369

PubMed Identifier: 23984357

Publication URI: http://europepmc.org/abstract/MED/23984357

Type: Journal Article/Review

Volume: 2013

Parent Publication: BioMed research international